NO161909C - Analogifremgangsmaate for fremstilling av farmasoeytisk anvendelige salter av 3-hydroksy-butansyre. - Google Patents

Analogifremgangsmaate for fremstilling av farmasoeytisk anvendelige salter av 3-hydroksy-butansyre.

Info

Publication number
NO161909C
NO161909C NO830618A NO830618A NO161909C NO 161909 C NO161909 C NO 161909C NO 830618 A NO830618 A NO 830618A NO 830618 A NO830618 A NO 830618A NO 161909 C NO161909 C NO 161909C
Authority
NO
Norway
Prior art keywords
pharmasoyytically
hydroxy
preparation
butanic acid
used salts
Prior art date
Application number
NO830618A
Other languages
English (en)
Other versions
NO830618L (no
NO161909B (no
Inventor
Jacques Lammerant
Jaroslaw Kolanowski
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Publication of NO830618L publication Critical patent/NO830618L/no
Publication of NO161909B publication Critical patent/NO161909B/no
Publication of NO161909C publication Critical patent/NO161909C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO830618A 1982-02-23 1983-02-22 Analogifremgangsmaate for fremstilling av farmasoeytisk anvendelige salter av 3-hydroksy-butansyre. NO161909C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8203100A FR2521857B1 (fr) 1982-02-23 1982-02-23 Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

Publications (3)

Publication Number Publication Date
NO830618L NO830618L (no) 1983-08-24
NO161909B NO161909B (no) 1989-07-03
NO161909C true NO161909C (no) 1989-10-11

Family

ID=9271331

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830618A NO161909C (no) 1982-02-23 1983-02-22 Analogifremgangsmaate for fremstilling av farmasoeytisk anvendelige salter av 3-hydroksy-butansyre.

Country Status (21)

Country Link
US (2) US4579955A (no)
EP (1) EP0087192B1 (no)
JP (1) JPS58201746A (no)
KR (1) KR910000143B1 (no)
AT (1) ATE24478T1 (no)
AU (2) AU560757B2 (no)
CA (1) CA1203242A (no)
DE (1) DE3368601D1 (no)
DK (1) DK163235C (no)
ES (2) ES8500240A1 (no)
FI (1) FI79523C (no)
FR (1) FR2521857B1 (no)
GR (1) GR77934B (no)
IE (1) IE54561B1 (no)
IL (1) IL67965A0 (no)
MX (1) MX156855A (no)
NO (1) NO161909C (no)
NZ (1) NZ203279A (no)
PH (1) PH21561A (no)
PT (1) PT76267A (no)
ZA (1) ZA831019B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
USRE38604E1 (en) 1984-06-22 2004-09-28 Btg International Limited Fluid therapy with L-lactate and/or pyruvate anions
US6020007A (en) * 1984-06-22 2000-02-01 Btg International Limited Fluid therapy with l-lactate and/or pyruvate anions
US4777288A (en) * 1987-06-11 1988-10-11 Pfizer Inc. Process for preparing a 4,4-diphenylbutanoic acid derivative
BE1001209A3 (fr) * 1987-11-19 1989-08-22 Solvay Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
US5292774A (en) * 1988-07-26 1994-03-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
DE4113984C2 (de) * 1991-04-29 2002-05-08 Koehler Chemie Dr Franz Salze der 4-Hydroxy-Buttersäure
ES2051222B1 (es) * 1992-03-12 1995-02-16 Sanmiguel Gabriel Serrano Procedimiento de neutralizacion de acido alfa-hidroxietanoico.
JP4598203B2 (ja) 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
DK2283834T3 (en) * 1997-03-17 2016-08-15 Btg Int Ltd Therapeutic compositions comprising ketone compounds and precursors thereof
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US6613356B1 (en) 2000-10-10 2003-09-02 Victor Vlahakos Weight loss medication and method
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
WO2006020137A2 (en) * 2004-07-16 2006-02-23 Ketocytonyx Inc. Oligomeric compounds
US7485743B2 (en) * 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds
WO2006012490A2 (en) * 2004-07-23 2006-02-02 Ketocytonyx Inc. Ketogenic saccharides
DK1796658T3 (en) * 2004-09-21 2016-06-27 Btg Int Ltd dopaminergic mimetics
US20070197645A1 (en) * 2004-09-21 2007-08-23 Martin Keith F Treatment of adhd
WO2008053982A1 (fr) 2006-10-30 2008-05-08 Ophtecs Corporation Composition pour le traitement de l'allergie
EP3659595A1 (en) 2012-11-05 2020-06-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ketone bodies to protect tissues from damage by ionizing radiation
WO2017086447A1 (ja) 2015-11-19 2017-05-26 協和発酵バイオ株式会社 ３－ヒドロキシイソ吉草酸の一価カチオン塩の結晶および該結晶の製造方法
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
JP6710098B2 (ja) * 2016-05-10 2020-06-17 大阪瓦斯株式会社 栄養剤組成物及び栄養補助食品
CN109476578A (zh) * 2016-06-24 2019-03-15 协和发酵生化株式会社 3-羟基异戊酸氨基酸盐的晶体及其制造方法
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
CN112341331B (zh) * 2019-08-07 2023-04-07 辽宁科硕营养科技股份有限公司 一种3-羟基丁酸盐及其制备方法与应用
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2101097A (en) * 1934-07-26 1937-12-07 Wm S Merrell Co Products for rendering the urine bacteriostatic
US2799684A (en) * 1954-06-18 1957-07-16 Food Chemical And Res Lab Inc Crystalline compounds of tryptophane and methods of manufacturing them
NL279760A (no) * 1961-06-17
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
DE2733202A1 (de) * 1976-08-04 1978-02-09 Agroferm Ag Verfahren zur herstellung der d(-)-3-hydroxybuttersaeure
US4412943A (en) * 1981-02-23 1983-11-01 Kao Soap Co., Ltd. Liquid detergent composition
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

Also Published As

Publication number Publication date
DK163235C (da) 1992-06-29
IE54561B1 (en) 1989-11-22
AU6916187A (en) 1987-05-21
ES8506283A1 (es) 1985-07-01
GR77934B (no) 1984-09-25
PH21561A (en) 1987-12-11
KR840003414A (ko) 1984-09-08
DK81583D0 (da) 1983-02-23
DK163235B (da) 1992-02-10
AU1162483A (en) 1983-09-01
EP0087192B1 (fr) 1986-12-30
JPS58201746A (ja) 1983-11-24
NO830618L (no) 1983-08-24
FR2521857A1 (fr) 1983-08-26
AU602329B2 (en) 1990-10-11
FI79523B (fi) 1989-09-29
DE3368601D1 (en) 1987-02-05
MX156855A (es) 1988-10-07
FR2521857B1 (fr) 1985-10-31
ES532880A0 (es) 1985-07-01
EP0087192A1 (fr) 1983-08-31
ZA831019B (en) 1983-11-30
IL67965A0 (en) 1983-06-15
CA1203242A (fr) 1986-04-15
AU560757B2 (en) 1987-04-16
US4771074A (en) 1988-09-13
ATE24478T1 (de) 1987-01-15
FI79523C (fi) 1990-01-10
ES519991A0 (es) 1984-10-01
PT76267A (fr) 1983-03-01
NZ203279A (en) 1985-04-30
KR910000143B1 (ko) 1991-01-21
FI830603A0 (fi) 1983-02-23
US4579955A (en) 1986-04-01
DK81583A (da) 1983-08-24
FI830603L (fi) 1983-08-24
IE830366L (en) 1983-08-23
ES8500240A1 (es) 1984-10-01
NO161909B (no) 1989-07-03

Similar Documents

Publication Publication Date Title
NO161909C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk anvendelige salter av 3-hydroksy-butansyre.
DK103384A (da) Quinoloncarboxylsyrer eller salte eller hydrater deraf, deres fremstilling og anvendelse som antibakterielle midler
HUP9701059A2 (hu) Stronciumsók alkalmazása ízületi bántalmak kezelésére alkalmas gyógyszerkészítmények előállítására
NZ225758A (en) Substituted amine derivatives; pharmaceutical compositions and processes for preparation
DK162222C (da) 2-amino-5-hydroxy-4-methylpyrimidin-derivater og farmeceutiske praeparater indeholdende disse
RO84704B (ro) Procedeu pentru prepararea unor derivati de n-piperidinil-benzamide
ES2056791T3 (es) Un procedimiento para preparar derivados de pirrolidinamida de acil aminoacido.
DK165988C (da) Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
NZ302072A (en) 1,3-diamino propyl stereomeric derivatives and organic acid and inorganic salts of their amine intermediates in the preparation of retroviral protease inhibitors
ES2059688T3 (es) Derivados de aminoacidos inhibidores de enzimas, procedimiento para su preparacion, agentes que los contienen y su utilizacion.
FR2575164B1 (fr) Esters de tri- et tetrapeptides inhibiteurs de la secretion gastrique, procede d'obtention et compositions pharmaceutiques les contenant
DK43080A (da) Cyclisk hexapeptid og foderstof indeholdende cyclisk hexapeptid
DOP2001000129A (es) Productos a base de uvas, fortificados con calcio y metodos para prepararlos.
GB1415471A (en) Phenylethylamine derivatives
EA200001107A1 (ru) ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ
DK0717048T3 (da) Cyclohexapeptider og deres blandinger, fremgangsmåde til fremstilling deraf samt deres anvendelse
ES2037003T3 (es) Procedimiento para preparar peptidos empleando percloratos.
NO973341L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.
DE3464486D1 (en) Derivatives of n-(4-acetylaminophenacyl)-amine, their therapeutical use and process for their preparation
BR0211780A (pt) Composto, e, composição farmacêutica
ES2075798B1 (es) Derivados de aminoacidos naturales como inhibidores de metaloproteinasas, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y el uso de dichos compuestos en medicina.